Literature DB >> 29593314

Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion.

Cheng Sun1,2, Peixiang Lan3, Qiuju Han3, Mei Huang4, Zhihong Zhang5, Geliang Xu4, Jiaxi Song1, Jinyu Wang1, Haiming Wei1, Jian Zhang3, Rui Sun1, Cai Zhang6, Zhigang Tian7,8.   

Abstract

A chronic viral or tumor microenvironment can push T cells to exhaustion by promoting coinhibitory ligand expression. However, how host factors control coinhibitory ligand expression and whether viral infection breaks this control during tumor progress is unknown. Here we show a close negative correlation between SALL4 or PD-L1 and miR-200c in tumors from 98 patients with HBV-related hepatocellular carcinoma. SALL4 or PD-L1 expression correlates negatively with miR-200c expression, and patients with lower levels of SALL4 or PD-L1 and higher miR-200c survive longer. Moreover, over-expression of miR-200c antagonizes HBV-mediated PD-L1 expression by targeting 3'-UTR of CD274 (encoding PD-L1) directly, and reverses antiviral CD8+ T cell exhaustion. MiR-200c transcription is inhibited by oncofetal protein SALL4, which is re-expressed through HBV-induced STAT3 activation in adulthood. We propose that an HBV-pSTAT3-SALL4-miR-200c axis regulates PD-L1. Therapeutic strategies to influence this axis might reverse virus-induced immune exhaustion.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29593314      PMCID: PMC5871883          DOI: 10.1038/s41467-018-03584-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  53 in total

1.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.

Authors:  P'ng Loke; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

2.  Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model.

Authors:  I-Tsu Chyuan; Hwei-Fang Tsai; Horng-Tay Tzeng; Chi-Chang Sung; Chien-Sheng Wu; Pei-Jer Chen; Ping-Ning Hsu
Journal:  Cell Mol Immunol       Date:  2015-02-09       Impact factor: 11.530

3.  Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.

Authors:  Darong Yang; Chaohui Zuo; Xiaohong Wang; Xianghe Meng; Binbin Xue; Nianli Liu; Rong Yu; Yuwen Qin; Yimin Gao; Qiuping Wang; Jun Hu; Ling Wang; Zebin Zhou; Bing Liu; Deming Tan; Yang Guan; Haizhen Zhu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

4.  IL-27 production and STAT3-dependent upregulation of B7-H1 mediate immune regulatory functions of liver plasmacytoid dendritic cells.

Authors:  Benjamin M Matta; Giorgio Raimondi; Brian R Rosborough; Tina L Sumpter; Angus W Thomson
Journal:  J Immunol       Date:  2012-04-16       Impact factor: 5.422

Review 5.  Targeting T Cell Co-receptors for Cancer Therapy.

Authors:  Margaret K Callahan; Michael A Postow; Jedd D Wolchok
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

6.  Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.

Authors:  Fenghua Wang; Aijun Liu; Yan Peng; Dinesh Rakheja; Lixin Wei; Debin Xue; Debing Xue; Robert W Allan; Kyle H Molberg; Jianping Li; Dengfeng Cao
Journal:  Am J Surg Pathol       Date:  2009-10       Impact factor: 6.394

7.  Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by down-regulating microRNA-513.

Authors:  Ai-Yu Gong; Rui Zhou; Guoku Hu; Jun Liu; Danuta Sosnowska; Kristen M Drescher; Haidong Dong; Xian-Ming Chen
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

Review 8.  Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

Authors:  Rita Diehl; Fabienne Ferrara; Claudia Müller; Antje Y Dreyer; Damian D McLeod; Stephan Fricke; Johannes Boltze
Journal:  Cell Mol Immunol       Date:  2016-10-10       Impact factor: 11.530

9.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

Review 10.  Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators.

Authors:  Isabelle Le Mercier; J Louise Lines; Randolph J Noelle
Journal:  Front Immunol       Date:  2015-08-21       Impact factor: 7.561

View more
  31 in total

1.  SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC.

Authors:  Chunlai Yin; Qiuju Han; Dongqing Xu; Bingqing Zheng; Xuemei Zhao; Jian Zhang
Journal:  Oncoimmunology       Date:  2019-04-17       Impact factor: 8.110

Review 2.  Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics.

Authors:  Hirohito Yamaguchi; Jung-Mao Hsu; Wen-Hao Yang; Mien-Chie Hung
Journal:  Nat Rev Clin Oncol       Date:  2022-02-07       Impact factor: 66.675

3.  The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4.

Authors:  Wenjuan Zhang; Yan Hu; Wenbing Zhang; Ke Yi; Xiaohui Xu; Zhihua Chen
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

4.  Ethyl Acetate Fraction from Hedyotis diffusa plus Scutellaria barbata Exerts Anti-Breast Cancer Effect via miR-200c-PDE7B/PD-L1-AKT/MAPK Axis.

Authors:  Yue Yang; Ting Fang; Yi-Lan Cao; Ya-Xin Lv; Qing-Qi Chang; Dan-Dan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-08-19       Impact factor: 2.629

5.  APN-mediated phosphorylation of BCKDK promotes hepatocellular carcinoma metastasis and proliferation via the ERK signaling pathway.

Authors:  Mengying Zhai; Zixia Yang; Chenrui Zhang; Jinping Li; Jing Jia; Lingyi Zhou; Rong Lu; Zhi Yao; Zheng Fu
Journal:  Cell Death Dis       Date:  2020-05-26       Impact factor: 8.469

Review 6.  Integrated cancer tissue engineering models for precision medicine.

Authors:  Michael E Bregenzer; Eric N Horst; Pooja Mehta; Caymen M Novak; Shreya Raghavan; Catherine S Snyder; Geeta Mehta
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

Review 7.  Recent Findings in the Regulation of Programmed Death Ligand 1 Expression.

Authors:  Xiangfeng Shen; Lihong Zhang; Jicheng Li; Yulin Li; Yishu Wang; Zhi-Xiang Xu
Journal:  Front Immunol       Date:  2019-06-14       Impact factor: 7.561

8.  The histone demethylase LSD1 promotes renal inflammation by mediating TLR4 signaling in hepatitis B virus-associated glomerulonephritis.

Authors:  Yi-Tong Yang; Xuan Wang; Yue-Yue Zhang; Wei-Jie Yuan
Journal:  Cell Death Dis       Date:  2019-03-20       Impact factor: 8.469

Review 9.  HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.

Authors:  Qiuju Han; Huajun Zhao; Yu Jiang; Chunlai Yin; Jian Zhang
Journal:  Cells       Date:  2019-06-08       Impact factor: 6.600

Review 10.  HBV-Induced Immune Imbalance in the Development of HCC.

Authors:  Yongyan Chen; Zhigang Tian
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.